✦ LIBER ✦

High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging

✍ Scribed by Craig H. Moskowitz; Joachim Yahalom; Andrew D. Zelenetz; Zhigang Zhang; Daniel Filippa; Julie Teruya-Feldstein; Tarun Kewalramani; Alison J. Moskowitz; Robert David Rice; Jocelyn Maragulia; Jill Vanak; Tanya Trippett; Paul Hamlin; Steven Horowitz; Ariela Noy; Owen A. O’Connor; Carol Portlock; David Straus; Stephen D. Nimer

Book ID: 108676635
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 939 KB
Volume: 148
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2009.08037.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Does the Addition of Involved Field Radi

Does the Addition of Involved Field Radiotherapy to High-dose Chemotherapy and Stem Cell Transplantation Improve Outcomes for Patients with Relapsed/Refractory Hodgkin Lymphoma?

✍ Kahn, S.T.; Flowers, C.; Xu, Z.; Esiashvili, N. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Patterns of failure following high dose

Patterns of failure following high dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease

✍ A.J. Mundt; Gregory Sibley; Stephanie Williams; Dennis Hallahan; Ralph Weichselb 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Salvage chemotherapy for relapsed or ref

Salvage chemotherapy for relapsed or refractory non-Hodgkin's lymphoma with a combination of ACES (high-dose Ara C, carboplatin, etoposide and steroids) therapy

✍ N. Niitsu; M. Umeda 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 390 KB

769 High dose therapy and autologous bon

769 High dose therapy and autologous bone marrow transplantation for relapsed or refractory hodgkin's disease: The impact of total body irradiation and involved field radiation therapy

✍ J.C. Poen; R.T. Hoppe; S.J. Horning; K.G. Blume 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Safety and feasibility of CHOP/rituximab

Safety and feasibility of CHOP/rituximab induction treatment followed by high-dose chemo/radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin's lymphoma

✍ Heß, G; Flohr, T; Huber, C; Kolbe, K; Derigs, H-G; Fischer, T 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 156 KB

Augmented high dose cyclophosphamide, et

Augmented high dose cyclophosphamide, etoposide, and carmustine followed by transplantation with peripheral blood stem cells (PBSC) in the treatment of relapsed or refractory Hodgkin’s disease

✍ J.E. Schwartz; M.J. Robertson; K.G. Cornetta; L.D. Cripe; R.P. Nelson; C.T. Yian 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 76 KB